Johnson & Johnson

Related company / holding

Insider activity · 24 months0 buys5 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 5 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€17.2M

▼ Sales (10 ops.)

€43.9M

Latest filing published 08 Jan 2026 for CVRx, Inc., €139k.

Filing timeline

BuySale

Johnson & Johnson

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Johnson & Johnson: trading record in brief

Filings by Johnson & Johnson span 8 companies, the busiest being CVRx, Inc., Protagonist Therapeutics, Inc and Fusion Pharmaceuticals Inc. Over a trading history stretching from 16 August 2016 to 26 November 2025, the count stands at 37 filings.

Market trades split into 2 purchases (€17.2M) and 10 sales (€43.9M). Sales outweigh purchases by €26.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 15 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

The latest filing, published on 8 January 2026, reports an open-market sale of €55k in CVRx, Inc. The most recent open-market purchase was published on 2 July 2020, 2,304 days ago. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.